Experiments have shown that, in CHF rats, ghrelin administration (100μg/kg, bid, 3 weeks) can increase plasma IGF-1 and long-term administration of ghrelin can increase ventricular posterior wall thickness, delay progression of LV dilatation, and decrease wall stress [40]. This evidence concerns the gene GHRL and congestive heart failure.